Circulating resistin levels are increased in patients with NAFLD and NASH, and circulating resistin levels in patients with NAFLD are related to the severity of steatosis, inflammation, and fibrosis [202,242,243]. The gene discussed is RETN; the disease is metabolic dysfunction-associated steatohepatitis.